Search Results

• • 689 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Can we use B-type natriuretic peptides to monitor patients with heart failure?

  Authors:Theresa A McDonagh, Roy S Gardner, Kwok S Chong, and Henry J DargieFrom:Biomarkers in Medicine (Vol. 1, Issue 3) Peer-Reviewed

  Oct. 20073,358 words Article Author(s): Theresa A McDonagh [[dagger]] 1 , Roy S Gardner 2 , Kwok S Chong 3 , Henry J Dargie 2 4 Keywords: heart failure; monitoring; natriuretic peptides; treatment titration The B-type natriuretic peptides...

• The relation between intraocular pressure change and plasma natriuretic peptide under simulated hypobaric conditions

  Authors:Remzi Karadag, Ahmet Sen, Nilgun Yildirim, Hikmet Basmak, Haydar Golemez, Erdinc Cakir, et al.From:Indian Journal of Ophthalmology (Vol. 58, Issue 3) Peer-Reviewed

  May-June 20102,979 words Report Byline: Remzi. Karadag, Ahmet. Sen, Nilgun. Yildirim, Hikmet. Basmak, Haydar. Golemez, Erdinc. Cakir, Ahmet. Akin Purpose: To ascertain whether the changes in intraocular pressure (IOP) that occur during hypobaric...

• The midregional fragment of pro-a-type natriuretic peptide, blood pressure, and mortality in a prospective cohort study of patients with type 2 diabetes (ZODIAC-25)

  Authors:Kornelis J.J. van Hateren, Gijs W.D. Landman, Nanne Kleefstra, Klaas H. Groenier, Joachim Struck, Gerjan J. Navis, et al.From:Diabetes Care (Vol. 36, Issue 5) Peer-Reviewed

  May 20134,263 words Clinical report 1360LOBJECTIVE--Evidence that midregional fragment of pro-A-type natriuretic peptide (MR-proANP) is a marker of mortality in patients with type 2 diabetes is limited. Therefore, we aimed to investigate the capabilities of...

• B-type natriuretic peptide modulates ghrelin, hunger, and satiety in healthy men

  Authors:Greisa Vila, Gabriele Grimm, Michael Resl, Birgit Heinisch, Elisa Einwallner, Harald Esterbauer, et al.From:Diabetes (Vol. 61, Issue 10) Peer-Reviewed

  Oct. 20123,157 words Report 1460LChronic heart failure is accompanied by anorexia and increased release of B-type natriuretic peptide (BNP) from ventricular cardiomyocytes. The pathophysiological mechanisms linking heart failure and appetite regulation...

• Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population. (Cardiovascular Medicine)

  Authors:M. Nakamura, H. Endo, M. Nasu, N. Arakawa, T. Segawa, and K. HiramoriFrom:Heart (Vol. 87, Issue 2) Peer-Reviewed

  Feb. 20024,139 words Article Background: Conflict exists regarding the usefulness of measuring plasma B type natriuretic peptide (BNP) concentrations for identifying impaired left ventricular (LV) systolic function during mass screening. Various...

• Cardioprotection of Controlled and Cardiac-Specific Over-Expression of A.sub.2A-Adenosine Receptor in the Pressure Overload

  Authors:Eman A. Hamad, Weizhong Zhu, Tung O. Chan, Valerie Myers, Erhe Gao, Xue Li, et al.From:PLoS ONE (Vol. 7, Issue 7) Peer-Reviewed

  July 6, 20125,341 words Article 1680LAuthor(s): Eman A. Hamad 1 , 2 , Weizhong Zhu 1 , * , Tung O. Chan 2 , Valerie Myers 1 , Erhe Gao 1 , Xue Li 2 , Jin Zhang 2 , Jianliang Song 1 , Xue-Qian Zhang 1 , Joseph Y. Cheung 1 , Walter Koch 1 , Arthur M. Feldman...

• Increased Activity of the Intracardiac Oxytocinergic System in the Development of Postinfarction Heart Failure

  Authors:Agnieszka Wsol, Kaja Kasarello, Marek Kuch, Kamila Gala, and Agnieszka Cudnoch- JedrzejewskaFrom:BioMed Research InternationalPeer-Reviewed

  Annual 20164,854 words Article 1360LAim. The present study was designed to test the hypothesis that the development of postinfarction heart failure is associated with a change of activity of the intracardiac oxytocinergic system. Methods. Experiments were...

• Correlation between B-type natriuretic peptide and functional/cognitive parameters in discharged congestive heart failure patients

  Authors:Laura Leto, Marzia Testa, and Mauro FeolaFrom:International Journal of EndocrinologyPeer-Reviewed

  Annual 20154,747 words Report 1450LThe determination of B-type natriuretic peptides (BNP) may have a role in the diagnosis of heart failure (HF) or guiding HF therapy. This study investigated the role of BNP determination in a cohort of elderly patients...

• Plasma concentrations of N-terminal atrial natriuretic peptide are raised in asymptomatic relatives of dilated cardiomyopathy patients with left ventricular enlargment. (Scientific Letter)

  Authors:J. Grzybowski, Z.T. Bilinska, J. Janas, E. Michalak, and W. RuzylloFrom:Heart (Vol. 88, Issue 2) Peer-Reviewed

  Aug. 20021,147 words Article The prognosis among patients with dilated cardiomyopathy (DCM) who present to a referral centre for heart failure management is poor, as the disease is usually well advanced by the time it is diagnosed. (1) There is...

• The effects of posture change and continuous positive airway pressure on cardiac natriuretic peptides in congestive heart failure

  Authors:Michael A. Wilkins, Xiao-Ling Su, Mark D. Palayew, Yoshihiro Yamashiro, Peter Bolli, John K. McKenzie, et al.From:Chest (Vol. 107, Issue 4) Peer-Reviewed

  Apr. 19954,310 words Article We studied changes in the peripheral plasma levels of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in seven patients with congestive heart failure (CHF) during four 1-h protocols during which...

• Intravenous B-type natriuretic peptide reduces wedge pressure in decompensated heart failure

  From:Formulary (Vol. 36, Issue 1) Peer-Reviewed

  Jan. 2001392 words Brief article The investigational agent nesiritide, a recombinant form of B-type natriuretic peptide, improves hemodynamic measures in acute decompensated heart failure, according to James Young, MD. He presented results of the phase...

• Increase in atrial natriuretic factor in the lungs, heart, and circulatory system owing to ozone

  Authors:David L. Vesely, Amy T. Giordano, Patricia Raska-Emery, and Mark R. MontgomeryFrom:Chest (Vol. 105, Issue 5) Peer-Reviewed

  May 19942,662 words Article Ozone can cause pulmonary edema and simultaneously decrease blood pressure. Atrial natriuretic factor (ANF) may mediate both of these effects in that it increases pulmonary capillary permeability resulting in edema...

• Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?

  Authors:Xiang Zhou and Jianchang ChenFrom:PLoS ONE (Vol. 9, Issue 5) Peer-Reviewed

  May 5, 20143,107 words Article 1370LBackground Whether additional benefit can be achieved with the use of trimetazidine (TMZ) in patients with chronic heart failure (CHF) remains controversial. We therefore performed a meta-analysis of randomized...

• Surfactant-Derived Proteins as Markers of Alveolar Membrane Damage in Heart Failure

  Authors:Paola Gargiulo, Cristina Banfi, Stefania Ghilardi, Damiano Magri, Marta Giovannardi, Alice Bonomi, et al.From:PLoS ONE (Vol. 9, Issue 12) Peer-Reviewed

  Dec. 16, 20145,854 words Article 1740LBackground In heart failure (HF) alveolar-capillary membrane is abnormal. Surfactant-derived proteins (SPs) and plasma receptor for advanced-glycation-end-products (RAGE) have been proposed as lung damage markers....

• High-Sensitivity Cardiac Troponin T: Risk Stratification Tool in Patients with Symptoms of Chest Discomfort

  Authors:Alma M. Mingels, Ivo A. Joosen, Mathijs O. Versteylen, Eduard M. Laufer, Mark H. Winkens, Joachim E. Wildberger, et al.From:PLoS ONE (Vol. 7, Issue 4) Peer-Reviewed

  Apr. 25, 20125,249 words Article 1440LBackground Recent studies have demonstrated the association between increased concentrations of high-sensitivity cardiac troponin T (hs-cTnT) and the incidence of myocardial infarction, heart failure, and mortality....

• Acute effects of insulin on circulating natriuretic peptide levels in humans

  Authors:Katherine N. Bachmann, Serpil Muge Deger, Aseel Alsouqi, Shi Huang, Meng Xu, Jane F. Ferguson, et al.From:PLoS ONE (Vol. 13, Issue 5) Peer-Reviewed

  May 14, 20185,500 words Report 1530LBackground The natriuretic peptide hormones play an important role in salt and blood pressure regulation. In observational studies, obesity and insulin resistance have been consistently associated with lower...

• Clinical Outcomes of Myocarditis after Moderate-Dose Steroid Therapy in Systemic Sclerosis: A Pilot Study.

  Authors:Burabha Pussadhamma, Thapanee Tipparot, Naruemol Chaosuwannakit, Ajanee Mahakkanukrauh, Siraphop Suwannaroj, Ratanavadee Nanagara, et al.From:International Journal of Rheumatology (Vol. 2020) Peer-Reviewed

  Dec. 21, 20207,408 words Clinical report 1490LBackground. Myocarditis is reported in systemic sclerosis (SSc); however, treatment options and outcomes are limited. Our objective was to define cardiac outcomes after moderate-dose steroid therapy in SSc patients with...

• Prognostic value of N[H.sub.2]-terminal pro B-type natriuretic peptide in patients with diabetes and stable coronary heart disease

  Authors:Charlotte Kragelund, Ida Gustafsson, Torbjorn Omland, Bjorn Gronning, Lars Kober, Jens Faber, et al.From:Diabetes Care (Vol. 29, Issue 6) Peer-Reviewed

  June 20061,832 words Disease/Disorder ove... 1600LCardiovascular disease is the most frequent cause of death in patients with diabetes (1). It is difficult to evaluate the cardiovascular status of patients with diabetes because of complex symptomology, evidence of...

• B-Type natriuretic peptide prevents acute hypertrophic responses in the diabetic rat heart: importance of cyclic GMP

  Authors:Anke C. Rosenkranz, Sally G. Hood, Robyn L. Woods, Gregory J. Dusting, and Rebecca H. RitchieFrom:Diabetes (Vol. 52, Issue 9) Peer-Reviewed

  Sept. 20035,082 words Article Stimulation of cardiomyocyte guanosine 3',5'-cyclic monophosphate (cyclic GMP) via endothelial-derived nitric oxide (NO) is an important mechanism by which bradykinin and ACE inhibitors prevent hypertrophy. Endothelial...

• Electrocardiographic Abnormalities and QT.sub.c Interval in Patients Undergoing Hemodialysis

  Authors:Yuxin Nie, Jianzhou Zou, Yixiu Liang, Bo Shen, Zhonghua Liu, Xuesen Cao, et al.From:PLoS ONE (Vol. 11, Issue 5) Peer-Reviewed

  May 12, 20165,775 words Report 1450LBackground Sudden cardiac death is one of the primary causes of mortality in chronic hemodialysis (HD) patients. Prolonged QT.sub.c interval is associated with increased rate of sudden cardiac death. The aim of this...